@inbook{28e9f765985144438c68582e87efb8aa,
title = "Pharmacogenetics of coumarin anticoagulant therapy",
abstract = "Coumarins are effective drugs for treatment and prevention of thromboembolic events. However, their use requires a balancing act between the chance of underdosing which increases the risk of thromboembolic events and the chance of overdosing which increases the risk of haemorrhages. It has been shown that polymorphisms in VKORC1 and CYP2C9 explain 35-50% of the dose variability, although patient characteristics and environmental factors also play a role. In this book chapter we discuss the pharmacogenetics of coumarin derivatives, clinical trials investigating the effectiveness of pre-treatment genotyping and the cost-effectiveness of pharmacogenetic-guided dosing.",
keywords = "Adverse drug reaction, Pharmacogenetics, Predictive genotyping, Translation, abacavir, coumarin, phenprocoumon, warfarin, anticoagulant therapy, bleeding, clinical practice, clinical trial (topic), cost effectiveness analysis, drug stability, environmental factor, genetic polymorphism, genetic variability, genotype, human, pharmacogenetics, predictive value, quality adjusted life year, thrombocytopenia, venous thromboembolism",
author = "{van Schie}, {Rianne M. F.} and Verhoef, {Talitha I.} and {de Boer}, Anthonius and {van der Meer}, {Felix J. M.} and Redekop, {William K.} and Tom Schalekamp and {Maitland-Van der Zee}, Anke-Hilse",
year = "2015",
month = may,
day = "3",
doi = "10.1007/978-3-319-15344-5_11",
language = "English",
isbn = "978-3-319-15343-8",
series = "Advances in Predictive, Preventive and Personalised Medicine ",
publisher = "Kluwer Academic Publishers, UK",
pages = "307--328",
editor = "Godfrey Grech",
booktitle = "Preventive and Predictive Genetics",
}